Literature DB >> 2183061

Modifications of the immune response induced by Histoplasma capsulatum products.

B H Ruiz1, R E Carvajal, L Ortiz-Ortiz.   

Abstract

To understand the host-parasite relationship in histoplasmosis, mice were inoculated with histoplasmin (HP), the filtrate of aged cultures of Histoplasma capsulatum, and the immune response of these mice towards sheep red blood cells (SRBC) and to trinitrophenyl hapten was studied. The filtrate abrogated completely the primary antibody response to both antigens as measured by the number of spleen hemolytic plaque forming cells when HP was administered at doses greater than 200 micrograms two days before the antigen. Suppression was elicited by HP when it was injected either intravenously, intraperitoneally, or subcutaneously. Inoculation with HP and antigen on the same day did not result in suppression. The secondary antibody response was not modified at any dose. Variation of the response with time was determined by counting the number of rosette forming cells (RFC) to SRBC every two days for a total of 21 days. Antibody-mediated RFC ('B' rosettes) were depressed throughout the experiment, while the number of non 'B', presumably T, RFC did not vary from control values. In animals inoculated with HP alone, high number of RFC were detected on day 11 after HP inoculation, suggesting that HP may have polyclonal activation effects. These results support the possibility that H. capsulatum evades the immune defenses by induction of a suppressive phenomenon in which the afferent limb of the immune response is not involved. This effect appeared to be induced directly by a product of the fungus, instead of by factors generated during the immune response to this microorganism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183061     DOI: 10.1007/BF00436999

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  46 in total

1.  A study of the whole yeast cell agglutination test in rabbits experimentally infected with Histoplasma capsulatum.

Authors:  G C COZAD
Journal:  J Immunol       Date:  1958-11       Impact factor: 5.422

2.  Immunomodulation by Histoplasma capsulatum products; polyclonal activation and mitogenic effects.

Authors:  B H Ruiz; R E Carvajal
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

3.  Membrane fractions of trypanosomes mimic the immunosuppressive and mitogenic effects of living parasites on the host.

Authors:  C E Clayton; D L Sacks; B M Ogilvie; B A Askonas
Journal:  Parasite Immunol       Date:  1979       Impact factor: 2.280

4.  Evidence of the existence of a factor that induces Fc receptors on bone marrow cells.

Authors:  M Calcagno; J R Pérez; M G Waldo; G Cabrera; B Weiss-Steider
Journal:  Blood       Date:  1982-04       Impact factor: 22.113

5.  Decreased suppressor cell activity in disseminated granulomatous infections.

Authors:  R P Artz; R R Jacobson; W E Bullock
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

6.  Immunoregulation in experimental disseminated histoplasmosis: flow microfluorometry (FMF) studies of the Thy and Lyt phenotypes of T lymphocytes from infected mice.

Authors:  S R Watson; T B Miller; T J Redington; W E Bullock
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

7.  Immunosuppressive effect of Entamoeba histolytica extract on hamsters.

Authors:  R Carvajal; B Ruiz; E Barjau
Journal:  Z Parasitenkd       Date:  1983

8.  Plaque Formation in Agar by Single Antibody-Producing Cells.

Authors:  N K Jerne; A A Nordin
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

9.  Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones.

Authors:  G S Deepe; J G Smith; G Sonnenfeld; D Denman; W E Bullock
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

10.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XII. Fine specificity of anti-idiotypic suppressor T cells (Ts2).

Authors:  D H Sherr; S T Ju; M E Dorf
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.